Monograph: Adalimumab (Rec.INN)
Index Nominum
Search in Index Nominum
All databases
Adalimumab (Rec.INN)
This content is only available to registered users
If you’re visiting this website the first time and would like to test the database free of charge for ten days, then click here to register once. After you’ve registered, log in with your user name and password.You’re already registered with DrugBase and would like to test the database free of charge for ten days without any further commitment? Then log in here with your access data and select the database you wish to test.
- Latin:
- Adalimumabum
- German:
- Adalimumab
- French:
- Adalimumab
- Spanish:
- Adalimumab
Therapeutical categories:
Anti-inflammatory agent
Disease-modifying antirheumatic drug, DMARD
Immunosuppressant
Monoclonal antibody
Tumor necrosis factor alpha (TNF-α) inhibitor
Disease-modifying antirheumatic drug, DMARD
Immunosuppressant
Monoclonal antibody
Tumor necrosis factor alpha (TNF-α) inhibitor
ATC:
- L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > L04: IMMUNOSUPPRESSANTS > L04A: IMMUNOSUPPRESSANTS > L04AA: Selective immunosuppressants > L04AA17: Adalimumab
- L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > L04: IMMUNOSUPPRESSANTS > L04A: IMMUNOSUPPRESSANTS > L04AB: Tumor necrosis factor alpha (TNF-Ã) inhibitors > L04AB04: Adalimumab
- Q: VETERINARY > QL: ANTINEOPLASTIC AND IMMUNOMODULATING AGEN > QL04: IMMUNOSUPPRESSANTS > QL04A: IMMUNOSUPPRESSANTS > QL04AA: Selective immunosuppressants > QL04AA17: Adalimumab [vet.]
CAS-No.:
0331731-18-1
